drug
Immunology
Preclinicalupdated 7mo agoby Dawn Sea Therapeutics
Preclinicalcommunity read0 votes
🐶 often sniffed alongside
top 8- tagImmunology80 co-mentions · 76 sources
- tag510(k) Clearance27 co-mentions · 27 sources
- tagAdCom27 co-mentions · 27 sources
- tagPsoriasis14 co-mentions · 4 sources
- tagPain14 co-mentions · 3 sources
- tagDiagnostics Company11 co-mentions · 11 sources
- tagLupus9 co-mentions · 5 sources
- tagOrthopedics7 co-mentions · 4 sources
all catalysts(0)
nothing on the calendar yet
News(10)
- STAT+: Up and down the ladder: The latest comings and goingsFrom new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.stat · 16h ago
- As part of sales reorganization, Novo will cut 215 employees at US HQFollow along as BioSpace tracks job cuts and restructuring initiatives.biospace · 17h ago
- Regeneron racks up another first as FDA greenlights generalized myasthenia gravis RNA drugThe go-ahead for Alnylam Pharmaceuticals–licensed Livsayis marks Regeneron’s second new modality this year after the company secured approval for hearing loss gene therapy Otarmeni in April.biospace · 1d ago
- With FDA nod, Regeneron brings an RNAi drug to autoimmune diseaseThe product of a collaboration with Alnylam, Livsayis is now Regeneron’s first marketed RNAi drug and will compete against established medicines from AstraZeneca and Argenx.biopharma_dive · 1d ago
- Vaccine biotech Evaxion halts infectious disease, autoimmune work to focus on oncologyEvaxion is refocusing its R&D efforts to solely focus on developing and advancing its cancer vaccines.fiercebiotech · 1d ago
- Pfizer leaps into ‘in vivo’ CAR-T with latest China dealThe potentially $2.6 billion collaboration puts Pfizer into a competitive race to treat autoimmune conditions by reprogramming cells inside the body.biopharma_dive · 2d ago
- Pfizer launches into autoimmune CAR T with China's Starna in up to $2.6B dealThe Chinese biotech will work with Pfizer on three in vivo CAR T therapies for autoimmune indications.biospace · 2d ago
- Pfizer enters in vivo CAR-T space via 3-program, $2.6B deal with China’s StarnaPfizer has decided to join the in vivo CAR-T race, penning a $2.6 billion deal for three preclinical candidates from China’s Starna Therapeutics.fiercebiotech · 2d ago
- At Fierce’s London event, Big Pharmas tell biotechs to ‘be transparent’ to secure dealsEvery biotech looking for a suitor wants to know: What does it take to charm a Big Pharma into a deal?fiercebiotech · 3d ago
- Isomorphic Labs breaks biotech VC fundraising record with $5B series CAfter securing $2.1 billion this May, AI-driven drug designer Isomorphic Labs is back with more money—a lot more—securing the industry’s largest private fundraise ever.biospace · 3d ago
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that